Replies to post #103019 on Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

I think Gerald is on the same page if the anticipated milestones come to fruition.

Next six weeks should add clarity as to what to expect in regards to the company's uplisting strategy.

Stay tuned for news.

Twitter: @AmarantusBio .... 10,000 followers.

p.s. I seriously doubt that the share price will ever go below .10 again. I expect Monday's closing price will substantially support this belief.

[JPetroInc]

Jac's - precisely right - forward looking PE's would peg this at right around 10 to 20 x's earnings - so your 13 multiplier is spot on Sir

I also believe Gerald calls it "financial engineering", with the understanding that the PPS will be quantified by certin milestones achievements - RiskReturn has a good feel for this - he would be a better resource for feedback

so it would appear they already have the uplisting 'financial model' tweeked and ready for data confirmation input to get the share price up there to reduce or avoid a RS entirely

a $2.00 pps requirement for a NASDAQ up-listing is definitely achievable

http://www.investopedia.com/ask/answers/121.asp